Uzatom and the Russia's Kurchatov Institute have signed a deal to advance Uzbekistan’s nuclear research, SMRs, and scientific ...

Penguin Solution shows AI infrastructure growth, Advanced Computing and memory gains, with sovereign AI driving durable ...

Advanced Threat Protection (ATP) is about the security measures and tools you put in place to defend against cyberattacks. It ...

PODpartner wraps up 2025 by launching Jumbo DTG and Embroidery Digitization, empowering 4,000+ brands with true creative freedom. We will carry the weight, so you can spread your wings. We will handle ...

What To Know: According to MLex, Alibaba is considering an order of between 40,000 and 50,000 units of AMD’s MI308 AI accelerators. This development serves as a potent counter-narrative to the bearish ...

PARK CITY — Olympic athletes are always chasing fractions of a second. Now, a Utah research team is testing whether the same cutting-edge materials that protect fighter jets at supersonic speeds could ...

In December 2025, Solventum announced updated consensus recommendations from an international panel on the clinical use of closed incision negative pressure therapy (ciNPT) with its proprietary ...

Many experts believed the Los Angeles Rams (7-2) would be at the top of the NFC through ten weeks of the season. Not many thought the same for the Seattle Seahawks (7-2) as their offense and defense ...

DS3610 Enters Clinical Development in Patients with Advanced Solid Tumors as First STING Agonist ADC in Industry-Leading ADC Portfolio of Daiichi Sankyo The first patient has been dosed in a ...

European car manufacturing is facing a pincer maneuver of threats. From the East, China’s automotive industry is stretching its wings across the global market. To the West, the lucrative American ...

Solid-state battery developer QuantumScape announced it hit another key goal for 2025, beginning shipments of its B1 sample cells featuring separators produced using its proprietary Cobra process. The ...

First presentation of clinical data from the sixth DXd antibody drug conjugate from the oncology pipeline of Daiichi Sankyo Early results support continued development of DS-3939, a potential first-in ...